HK2 and glioblastoma: Interestingly, our data suggests that high expression levels of HK2, and PKM2 appear to have important clinical implication for patients with GBM and in agreement with studies demonstrating that inhibition of glycolysis improves survival in GBM (McKelvey et al., 2021).